Page last updated: 2024-08-24

ranolazine and Acute Disease

ranolazine has been researched along with Acute Disease in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (66.67)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Davangeri, R; Hashilkar, NK; Majagi, SI; Naveena, R1
Ameen, AM; Tawfik, MK1
Braunwald, E; Karwatowska-Prokopczuk, E; McCabe, CH; Morrow, DA; Scirica, BM; Skene, A1
Belardinelli, L; Braunwald, E; Gersh, BJ; Hedgepeth, CM; Hod, H; McCabe, CH; Molhoek, P; Morrow, DA; Murphy, SA; Scirica, BM; Verheugt, FW1
Braunwald, E; Giugliano, RP1
Melloni, C; Newby, LK1

Reviews

1 review(s) available for ranolazine and Acute Disease

ArticleYear
The year in non-ST-segment elevation acute coronary syndrome.
    Journal of the American College of Cardiology, 2007, Oct-02, Volume: 50, Issue:14

    Topics: Acetanilides; Acute Disease; Age Factors; Aged; Biomarkers; Bone Morphogenetic Proteins; Cardiac Catheterization; Cardiology; Coronary Disease; Electrocardiography; Enzyme Inhibitors; Female; Fibrinolytic Agents; Glucose Metabolism Disorders; Growth Differentiation Factor 15; Hemorrhage; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Myocardial Ischemia; Piperazines; Practice Guidelines as Topic; Quality Assurance, Health Care; Ranolazine; Risk Assessment; Sex Factors

2007

Trials

2 trial(s) available for ranolazine and Acute Disease

ArticleYear
Evaluation of a novel anti-ischemic agent in acute coronary syndromes: design and rationale for the Metabolic Efficiency with Ranolazine for Less Ischemia in Non-ST-elevation acute coronary syndromes (MERLIN)-TIMI 36 trial.
    American heart journal, 2006, Volume: 151, Issue:6

    Topics: Acetanilides; Acute Disease; Aged; Angina, Unstable; Double-Blind Method; Enzyme Inhibitors; Female; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Piperazines; Ranolazine; Syndrome

2006
Effect of ranolazine, an antianginal agent with novel electrophysiological properties, on the incidence of arrhythmias in patients with non ST-segment elevation acute coronary syndrome: results from the Metabolic Efficiency With Ranolazine for Less Ischem
    Circulation, 2007, Oct-09, Volume: 116, Issue:15

    Topics: Acetanilides; Acute Disease; Aged; Angina Pectoris; Arrhythmias, Cardiac; Coronary Disease; Diabetic Angiopathies; Electrocardiography; Electrophysiology; Female; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Piperazines; Placebos; Ranolazine; Tachycardia; Thrombolytic Therapy

2007

Other Studies

3 other study(ies) available for ranolazine and Acute Disease

ArticleYear
Effect of anti-inflammatory activity of ranolazine in rat model of inflammation.
    The Indian journal of medical research, 2018, Volume: 148, Issue:6

    Topics: Acute Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Carrageenan; Edema; Granuloma, Foreign-Body; Gum Arabic; Inflammation; Male; Random Allocation; Ranolazine; Rats, Wistar

2018
Cardioprotective effect of ranolazine in nondiabetic and diabetic male rats subjected to isoprenaline-induced acute myocardial infarction involves modulation of AMPK and inhibition of apoptosis.
    Canadian journal of physiology and pharmacology, 2019, Volume: 97, Issue:7

    Topics: Acute Disease; AMP-Activated Protein Kinases; Animals; Apoptosis; Blood Glucose; Cardiotonic Agents; Diabetes Mellitus, Experimental; Electrocardiography; Glycated Hemoglobin; Isoproterenol; Male; Myocardial Infarction; Oxidative Stress; Ranolazine; Rats; Rats, Wistar

2019
Metabolic efficiency with ranolazine for less ischemia in non-ST elevation acute coronary syndromes (MERLIN TIMI-36) study.
    Expert review of cardiovascular therapy, 2008, Volume: 6, Issue:1

    Topics: Acetanilides; Acute Coronary Syndrome; Acute Disease; Angina Pectoris; Cardiovascular Agents; Coronary Disease; Double-Blind Method; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Male; Middle Aged; Myocardial Infarction; Piperazines; Quality of Life; Randomized Controlled Trials as Topic; Ranolazine; Recurrence; Sex Factors; Thrombolytic Therapy

2008